Patents by Inventor Daniel HALBIG

Daniel HALBIG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240424216
    Abstract: In one instance, disclosed herein is an auto-injector, the auto-injector including: a housing; a container disposed within the housing, the container configured to store a medicament; a canister disposed within the housing, the canister configured to release a pressurized medium to expel the medicament from the container; a shroud coupled to the housing, the shroud configured to move between a first position and a second position relative to the housing to cause the pressurized medium to be released by the canister; and a mandrel assembly disposed within the housing, the mandrel assembly configured to urge the shroud outward relative to the housing toward the first position after the pressurized medium is released by the canister.
    Type: Application
    Filed: June 20, 2024
    Publication date: December 26, 2024
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Daniel HALBIG, Alexander ROUMANIDAKIS, Bryan GRYGUS, Danielle Laiacona, Sindhuja Kuchibhatla, John Burke, Daniel O’Connell-Govan
  • Publication number: 20240382677
    Abstract: An injection device may include a housing, a container disposed within the housing, the container enclosing a fluid and having a first end and a second end, a conduit movable relative to the container, wherein the conduit is not in fluid communication with the fluid enclosed by the container while in a first position, and is in fluid communication with the fluid enclosed by the container and configured to deliver the fluid from the container to a patient while in a second position, and a lock that is removable from the housing, the lock having a first portion and a second portion.
    Type: Application
    Filed: May 16, 2024
    Publication date: November 21, 2024
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Bryan C. GRYGUS, Trevor Langley, Daniel Halbig, Ross Kenyon, Alfred Marino, Wayne Phillips, Jeff Moore, Sten Nygaard, Jan Norup, David Farrage, Jeremy Odegard, Jeremy McNamara
  • Publication number: 20240350748
    Abstract: Needle spacers for use in administering subcutaneous injections, as well as subcutaneous injection systems including such needle spacers, are disclosed. In certain embodiments, the needle spacer comprises a first portion configured to engage a hub of a needle that comprises such a hub; and a second portion coupled to the first portion and extending distally therefrom, the second portion including a skin-contacting surface disposed on a distal end thereof, wherein the skin-contacting surface is configured to engage a surface of skin of a subject. The second portion is configured to maintain a predetermined distance between the hub of the needle and the surface of the skin, and to permit insertion of the needle to a depth of about 4 mm to about 8 mm below the surface of the skin during administration of a subcutaneous injection via the needle.
    Type: Application
    Filed: April 18, 2024
    Publication date: October 24, 2024
    Inventors: Daniel HALBIG, Matthew PAUSLEY, Thomas MADDEN, Alexander ROUMANIDAKIS, Sarah ELLIS, Eric HOLOWKA, Trevor LANGLEY, Jessica MASTROPIETRO, Megan THOMPSON
  • Publication number: 20240278712
    Abstract: A method for operating a taillight of a motor vehicle, wherein the taillight, in particular in addition to a functional light source assigned to at least one further light function, has a taillight source assigned to a taillight function, having a plurality of lighting regions that can be controlled independently with respect to operation and brightness, wherein at least one environment sensor of the motor vehicle records sensor data describing other traffic participants behind within a predefined distance range from the rear of the motor vehicle, wherein if at least one activation criterion evaluating the sensor data and checking for the presence of at least one further traffic participant within a predetermined distance range from the rear of the motor vehicle, a brightness-increasing switching operation, in particular an activation and/or a dimming, of a second lighting region of the taillight source which was previously inactive or is operating with lower brightness than at least one other, first lighting
    Type: Application
    Filed: June 17, 2021
    Publication date: August 22, 2024
    Applicant: AUDI AG
    Inventors: Valentin SCHMIDT, Daniel HALBIG, Ernst REITER, Roman HORST, Viktor HAHN
  • Publication number: 20240075204
    Abstract: An auto-injector may include a container capable of comprising a medicament; a shuttle coupled to the container and on a horizontal path with a first state and a second state; an energy source configured to release energy to translate the container and to translate the shuttle, preferably the energy source is pressurized fluid from a can; an impediment preventing horizontal movement of the shuttle before activation of the auto-injector; and a needle having a first end configured to extend out of the auto-injector, and a second end configured to extend into the container, wherein the second end of the needle and the container are not in fluid communication with one another before activation of the auto-injector.
    Type: Application
    Filed: June 29, 2023
    Publication date: March 7, 2024
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Daniel HALBIG, Bryan GRYGUS, Trevor LANGLEY, Andrew DUMONT, Bart E. BURGESS, Matthew PAUSLEY, Ross KENYON
  • Publication number: 20230233770
    Abstract: A drug delivery device is disclosed, wherein the device comprises a housing; a product container arranged in the housing; a plunger rod partially disposed inside the product container; and a thumb pad configured to receive a portion of the plunger rod, wherein the thumb pad and the plunger rod are configured to transition from a first state to a second state, wherein at the first state, the plunger rod is prevented from moving in a proximal direction, and at the second state, the plunger rod moves freely in a proximal direction.
    Type: Application
    Filed: January 25, 2023
    Publication date: July 27, 2023
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Trevor LANGLEY, Bryan GRYGUS, Daniel HALBIG, Paige WAECHTER, Andrew DUMONT, Parker VALDEZ, Sindhuja KUCHIBHATLA
  • Publication number: 20230225944
    Abstract: A vial adapter assembly that includes a housing, a first receptacle formed within the housing and configured to receive a first vial within the housing, and a second receptacle formed within the housing and configured to receive a second vial within the housing. An opening of the first receptacle and an opening of the second receptacle is in fluid communication with the upper surface of the housing. The vial adapter assembly includes a cap that is coupled and movable relative to the housing from a closed configuration to an open configuration. In the closed configuration, the cap is configured to cover the opening of the first receptacle and the opening of the second receptacle on the upper surface. In the open configuration, the cap is configured to uncover the opening of the first receptacle and the opening of the second receptacle, and expose the upper surface.
    Type: Application
    Filed: January 17, 2023
    Publication date: July 20, 2023
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Bryan GRYGUS, Daniel HALBIG, Eric HOUDE, Prithvi SINGH, Paige WAECHTER, Parker VALDEZ, Sandy SPENCER, Sindhuja KUCHIBHATLA, Trevor LANGLEY
  • Publication number: 20230105585
    Abstract: An injection device includes a carrier, a needle, a driver coupled to the needle, the driver being slidable relative to the carrier between a retracted configuration and a deployed configuration, a shuttle configured to move the driver between the retracted configuration and the deployed configuration, and a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move the driver from the deployed configuration to the retracted configuration.
    Type: Application
    Filed: December 8, 2022
    Publication date: April 6, 2023
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Bryan C. GRYGUS, Alfred MARINO, Rachel P. ARNOTT, Scott BARTON, Bart E. BURGESS, Richard GILDERSLEEVE, Alexei GORALTCHOUK, Daniel HALBIG, Christopher KANEL, Trevor LANGLEY
  • Patent number: 11547801
    Abstract: An injection device includes a carrier, a needle, a driver coupled to the needle, the driver being slidable relative to the carrier between a retracted configuration and a deployed configuration, a shuttle configured to move the driver between the retracted configuration and the deployed configuration, and a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move the driver from the deployed configuration to the retracted configuration.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: January 10, 2023
    Assignee: REGENERON PHARMACEUTICALS, INC.
    Inventors: Bryan C. Grygus, Alfred Marino, Rachel P. Arnott, Scott Barton, Bart E. Burgess, Richard Gildersleeve, Alexei Goraltchouk, Daniel Halbig, Christopher Kanel, Trevor Langley
  • Publication number: 20220370721
    Abstract: Disclosed herein are devices and methods for delivering a predetermined volume of a drug substance or other product including a fluid. An exemplary device may include a body configured to receive a drug substance therein, and a plunger rod disposed at least partially inside the body to distally move a stopper in the body. The device may include a component configured to regulate distal movement of the plunger rod in a priming step and in a subsequent delivery step, so that the device may be accurately primed and may accurately dispense a predetermined volume of a drug substance.
    Type: Application
    Filed: August 1, 2022
    Publication date: November 24, 2022
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Trevor LANGLEY, Justin BECHSTEIN, Jeremy ODEGARD, Sibgat ULLA, Daniel HALBIG, Bryan GRYGUS, Prithvi SINGH, Andrew DUMONT, David NETT, Tasha GILLUM, Ryan AINSWORTH
  • Patent number: 11439758
    Abstract: Disclosed herein are devices and methods for delivering a predetermined volume of a drug substance or other product including a fluid. An exemplary device may include a body configured to receive a drug substance therein, and a plunger rod disposed at least partially inside the body to distally move a stopper in the body. The device may include a component configured to regulate distal movement of the plunger rod in a priming step and in a subsequent delivery step, so that the device may be accurately primed and may accurately dispense a predetermined volume of a drug substance.
    Type: Grant
    Filed: June 22, 2021
    Date of Patent: September 13, 2022
    Assignee: REGENERON PHARMACEUTICALS, INC.
    Inventors: Trevor Langley, Justin Bechstein, Jeremy Odegard, Sibgat Ulla, Daniel Halbig, Bryan Grygus, Prithvi Singh, Andrew Dumont, David Nett, Tasha Gillum, Ryan Ainsworth
  • Publication number: 20220203032
    Abstract: An auto-injector may include a container capable of comprising a medicament; a shuttle coupled to the container and on a horizontal path with a first state and a second state; an energy source configured to release energy to translate the container and to translate the shuttle, preferably the energy source is pressurized fluid from a can; an impediment preventing horizontal movement of the shuttle before activation of the auto-injector; and a needle having a first end configured to extend out of the auto-injector, and a second end configured to extend into the container, wherein the second end of the needle and the container are not in fluid communication with one another before activation of the auto-injector.
    Type: Application
    Filed: December 29, 2021
    Publication date: June 30, 2022
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Daniel HALBIG, Bryan GRYGUS, Trevor LANGLEY, Andrew DUMONT, Bart E. BURGESS, Matthew PAUSLEY, Ross KENYON
  • Publication number: 20220193343
    Abstract: An auto-injector may include a housing having a longitudinal axis and a transverse axis, the housing having a shorter dimension along the transverse axis than along the longitudinal axis, wherein the transverse axis is perpendicular to the longitudinal axis; a flowpath having a first end and a second end; and a container enclosing a first fluid, the container extending from a first end toward a second end along or parallel to the longitudinal axis and being movable from a first position to a second position along or parallel to the longitudinal axis, the container being fluidly isolated from the flowpath in the first position and fluidly connected to the flowpath in the second position.
    Type: Application
    Filed: December 29, 2021
    Publication date: June 23, 2022
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Bart BURGESS, Bryan GRYGUS, Daniel HALBIG, Ross KENYON, Trevor LANGLEY, Jeremy MCNAMARA, Matthew PAUSLEY, Andrew DUMONT, Paige WAECHTER, John BURKE, Martin BONTOFT, Craig MCGARRELL, Scott MARTIN, James Nicholas MOWER, James Cunningham GLENCROSS, James Donald MCLUSKY, Andrew LABAT-ROCHECOUSTE, Tim QUIGG, Matt HILL, Matthew PHILLIPPO, Kirsty WYNNE
  • Publication number: 20220160968
    Abstract: Disclosed herein are devices and methods for delivering a predetermined volume of a drug substance or other product including a fluid. An exemplary device may include a body configured to receive a drug substance therein, and a plunger rod disposed at least partially inside the body to distally move a stopper in the body. The device may include a component configured to regulate distal movement of the plunger rod in a priming step and in a subsequent delivery step, so that the device may be accurately primed and may accurately dispense a predetermined volume of a drug substance.
    Type: Application
    Filed: December 3, 2021
    Publication date: May 26, 2022
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Trevor LANGLEY, Justin BECHSTEIN, Jeremy ODEGARD, Sibgat ULLA, Daniel HALBIG, Bryan GRYGUS, Prithvi SINGH, Andrew DUMONT, David NETT, Tasha GILLUM, Ryan AINSWORTH
  • Publication number: 20220118177
    Abstract: An auto-injector may include a housing having a longitudinal axis and a transverse axis, the housing having a shorter dimension along the transverse axis than along the longitudinal axis, wherein the transverse axis is perpendicular to the longitudinal axis; a flowpath having a first end and a second end; and a container enclosing a first fluid, the container extending from a first end toward a second end along or parallel to the longitudinal axis and being movable from a first position to a second position along or parallel to the longitudinal axis, the container being fluidly isolated from the flowpath in the first position and fluidly connected to the flowpath in the second position.
    Type: Application
    Filed: December 29, 2021
    Publication date: April 21, 2022
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Bart BURGESS, Bryan GRYGUS, Daniel HALBIG, Ross KENYON, Trevor LANGLEY, Jeremy MCNAMARA, Matthew PAUSLEY, Andrew DUMONT, Paige WAECHTER, John BURKE, Martin BONTOFT, Craig MCGARRELL, Scott MARTIN, James Nicholas MOWER, James Cunningham GLENCROSS, James Donald MCLUSKY, Andrew LABAT-ROCHECOUSTE, Tim QUIGG, Matt HILL, Matthew PHILLIPPO, Kirsty WYNNE
  • Publication number: 20210330887
    Abstract: Disclosed herein are devices and methods for delivering a predetermined volume of a drug substance or other product including a fluid. An exemplary device may include a body configured to receive a drug substance therein, and a plunger rod disposed at least partially inside the body to distally move a stopper in the body. The device may include a component configured to regulate distal movement of the plunger rod in a priming step and in a subsequent delivery step, so that the device may be accurately primed and may accurately dispense a predetermined volume of a drug substance.
    Type: Application
    Filed: June 22, 2021
    Publication date: October 28, 2021
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Trevor LANGLEY, Justin BECHSTEIN, Jeremy ODEGARD, Sibgat ULLA, Daniel HALBIG, Bryan GRYGUS, Prithvi SINGH, Andrew DUMONT, David NETT, Tasha GILLUM, Ryan AINSWORTH